Physician profile
Tracy Freeman
NPI 1265671275
$1,183.39
in general payments reported to CMS, 2019-2025
16 companies · $172 in 2025
The $172 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $101 · 2020: $36.77 · 2021: $326 · 2022: $257 · 2023: $113 · 2024: $178 · 2025: $172.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $463.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $462.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Corcept Therapeutics | $381.16 | 2020-2022 | |
| Grifols USA, LLC | $321.79 | 2019-2025 | Prolastin-C Liquid |
| Acella Pharmaceuticals, LLC | $140.03 | 2022-2025 | NP Thyroid 60 |
| Vivus LLC | $46.43 | 2019 | |
| Romark Laboratories, Lc | $40.07 | 2019 | |
| Alnylam Pharmaceuticals INC. | $30.79 | 2025 | Givlaari |
| Alfasigma USA, INC. | $30.61 | 2020-2021 | |
| Lilly USA, LLC | $30.29 | 2024 | Mounjaro, Zepbound |
| Avion Pharmaceuticals | $28.38 | 2024 | NP Thyroid 60 |
| Phadia US INC. | $23.47 | 2022 | |
| Nestle Healthcare Nutrition INC. | $20.68 | 2022 | |
| Ibsa Pharma INC. | $19.67 | 2022 | |
| Azurity Pharmaceuticals, INC. | $19.50 | 2023 | Adthyza |
| Novo Nordisk INC | $19.36 | 2023 | Wegovy, Saxenda |
| Kerecis Limited | $16.65 | 2021 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Molnlycke Health Care US, LLC | $14.51 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tracy Freeman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.